Search
Selected Filter
Displaying 1–10 of 281 research results
-
Editas Reports Results for 14 Participants in its Phase 1/2 CRISPR/Cas9 Clinical Trial for LCA10
Eye On the Cure Research NewsThe company is seeking a partner to move the LCA10 program forward
-
Recap of Retinal Disease News from the 2022 Meeting of the American Academy of Ophthalmology
Eye On the Cure Research NewsReports on emerging therapies for dry age-related macular degeneration (geographic atrophy), Stargardt disease, and X-linked retinitis pigmentosa are included
-
Age-Related Macular Degeneration Research Advances
Retinal Disease Research AdvancesRecent developments in research on age-related macular degeneration.
-
Retinitis Pigmentosa Research Advances
Retinal Disease Research AdvancesRecent developments in research on retinitis pigmintosa.
-
Usher Syndrome Research Advances
Retinal Disease Research AdvancesRecent developments in research on Usher Syndrome.
-
Stargardt Disease Research Advances
Retinal Disease Research AdvancesRecent developments in research on Stargardt disease
-
Leber Congenital Amaurosis Research Advances
Retinal Disease Research AdvancesRecent developments in research on Leber congenital amaurosis
-
Atsena’s LCA-GUCY2D Gene Therapy Improves Vision in Phase 1/2 Clinical Trial
Eye On the Cure Research NewsThe company is planning to move the emerging treatment into a pivotal trial
-
Eye On the Cure Research News
Small data sets present challenges for developing rare disease AI tools
-
Iveric Bio’s Zimura for Advanced Dry AMD Meets Endpoint in Second Phase 3 Clinical Trial
Eye On the Cure Research NewsThe company plans to seek FDA approval for the emerging therapy in first quarter of 2023
.png)
